5-Amino-1MQ Product & Research Brief

1. Compound Overview

 (5-Amino-1-methylquinolinium) is a research compound investigated for its ability to inhibit the enzyme Nicotinamide N-Methyltransferase (NNMT). NNMT is associated with metabolic regulation, fat storage, and cellular NAD+ balance. By inhibiting NNMT, researchers believe this compound may influence energy metabolism and fat oxidation.

2. Key Mechanism (NNMT Pathway)

• NNMT activity is elevated in obesity and metabolic dysfunction.
  • High NNMT lowers NAD+ availability in cells.
  • Lower NAD+ reduces mitochondrial efficiency.
  • 5-Amino-1MQ inhibits NNMT activity.
  • NAD+ levels may increase.
  • Higher NAD+ supports mitochondrial energy production and fat oxidation.

3. Potential Benefits Being Studied

• Fat metabolism enhancement
• Reduced adiposity in animal studies
• Improved metabolic efficiency
• Possible insulin sensitivity improvements
• Potential lean mass preservation during fat loss
• Possible appetite changes secondary to metabolic effects

4. Suggested Research Vial Sizes

• 50 mg vial
• 100 mg vial
• 150 mg vial
• 200 mg vial

5. Example Reconstitution Chart

6. Example Label Information

• Compound name: 5-Amino-1MQ
• Amount per vial
• Batch / lot number
• Manufacture date
• Research use only disclaimer
• Storage instructions (2–8°C recommended)

7. Market Positioning

5-Amino-1MQ is commonly marketed within the metabolic research category. It is often positioned alongside compounds related to fat metabolism, mitochondrial health, and NAD+ pathways.

8. Example Research Stacks Discussed

• 5-Amino-1MQ + NAD+
• 5-Amino-1MQ + MOTS-C
• 5-Amino-1MQ + Semaglutide
• 5-Amino-1MQ + Tirzepatide

9. Safety & Regulatory Notes

This compound is not FDA approved and remains a research chemical. Information provided in this document is for research discussion purposes only and not intended as medical guidance.